Can AI help radiologists see what humans can’t—and speed up drug development in the process?

In this episode of SNiPs, Dr. Ben Larimer joins Bracken CEO Dr. Colin Miller to explore how artificial intelligence and machine learning are redefining what’s possible in molecular imaging. From interpreting complex PET scans to designing radiopharmaceuticals faster than ever, the future of diagnostics is being shaped by intelligent tools.

Dr. Larimer shares real-world examples of how AI is already shaping radiopharmaceutical innovation and clinical trial design—and why the era of data-driven diagnostics is just getting started.

Topics include:

• PET imaging and tumor heterogeneity
• AI-assisted radiology
• Accelerating development of imaging agents
• The promise of radiomics and multimodal data
• Tune in now and explore how intelligent tools are reshaping life sciences from pixel to patient.